Joseph P Hagan is Chief Executive Officer of Regulus Therapeutics Inc.. Currently has a direct ownership of 57,112 shares of RGLS, which is worth approximately $87,381. The most recent transaction as insider was on Jan 18, 2024, when has been sold 14,580 shares (Common Stock) at a price of $1.19 per share, resulting in proceeds of $17,350. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 57.1K
0% 3M change
86.3% 12M change
Total Value Held $87,381

Joseph P Hagan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 18 2024
SELL
Open market or private sale
$17,350 $1.19 p/Share
14,580 Reduced 20.34%
57,112 Common Stock
Jan 12 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 29.5%
71,692 Common Stock
Jan 26 2022
BUY
Open market or private purchase
$22,000 $0.22 p/Share
100,000 Added 19.34%
417,006 Common Stock
May 17 2021
SELL
Open market or private sale
$3,726 $0.89 p/Share
4,186 Reduced 1.31%
316,292 Common Stock
Apr 14 2021
BUY
Conversion of derivative security
-
75,850 Added 19.14%
320,478 Common Stock
Feb 16 2021
SELL
Open market or private sale
$7,128 $1.72 p/Share
4,144 Reduced 0.85%
485,756 Common Stock
Nov 16 2020
SELL
Open market or private sale
$3,169 $0.52 p/Share
6,094 Reduced 2.74%
215,994 Common Stock

Also insider at

ZSANQ
Zosano Pharma Corp
AUPH
Aurinia Pharmaceuticals Inc. Healthcare
JPH

Joseph P Hagan

Chief Executive Officer
Victoria, A1

Track Institutional and Insider Activities on RGLS

Follow Regulus Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGLS shares.

Notify only if

Insider Trading

Get notified when an Regulus Therapeutics Inc. insider buys or sells RGLS shares.

Notify only if

News

Receive news related to Regulus Therapeutics Inc.

Track Activities on RGLS